References

Bergquist, N.R., 1995. Schistosomiasis vaccine development: Approaches and prospects Mem. Inst. Oswaldo. Cruz., 90: 221-227.
PubMed  |  

Bergquist, N.R., 2002. Schistosomiasis: From risk assessment to control. Trends Parasitol., 18: 309-314.
CrossRef  |  

Boros, D.L., 1989. Immunopathology of Schistosoma mansoni infection. Clin. Microbiol. Rev., 2: 250-269.
PubMed  |  

Cass, C.L., J.R. Johnson, L.L. Califf, T. Xu and H.J. Hernandez et al., 2007. Proteomic analysis of Schistosoma mansoni egg secretions Mol. Biochem. Parasitol., 155: 84-93.
CrossRef  |  

Clegg, J.A. and S.R. Smithers, 1972. The effects of immune rhesus monkey serum on Schistosoma mansoni during cultivation in vitro. Int. J. Parasitol., 2: 79-98.
PubMed  |  

Crabtree, J.E. and R.A. Wilson, 1986. The role of pulmonary cellular reactions in the resistance of vaccinated mice to Schostosoma mansoni. Parasite Immunol., 8: 265-285.
PubMed  |  

Dean, D.A. and B.L. Mangold, 1992. Evidence that both normal and immune elimination of Schistosoma mansoni take place at the lung stage of migration prior to parasite death Am. J. Trop. Med. Hyg., 47: 238-248.
PubMed  |  

Dean, D.A., B.L. Mangold, J.R. Georgi and R.H. Jacobson, 1984. Comparison of Schistosoma mansoni migration patterns in normal and irradiated cercariae-immunized mice by means of autoradio-graphic analysis Am. J. Trop. Med. Hyg., 33: 89-96.
PubMed  |  

Doenhoff, M.J., S. Pearson, D.W. Dunne, Q. Bickle, S. Lucas, J. Bain and O. Hassounah, 1981. Immunological control of hepatotoxicity and parasite egg excretion in Schistosoma mansoni infection: Stage specificity of the relativity of immune serum in T-cell deprived mice Trans. R. Soc. Trop. Med. Hyg., 75: 41-53.

Dunne, D.W., S. Lucas, Q. Bickle, S. Pearson, L. Madgwick, J. Bain and M.J. Doenhoff, 1981. Identification and purification of an antigen (W1) from Schistosoma mansoni eggs which is putatively hepatotoxic in T-cell deprived mice Trans. R. Soc. Trop. Med. Hyg., 75: 54-71.
PubMed  |  

Farias, L.P., F.C. Cardoso, P.A. Miyasato, B.O. Montoya and C.A. Tararam et al., 2010. Schistosoma mansoni stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection. PloS. Negl. Trop. Dis., Vol. 4. 10.1371/journal.pntd.0000597

Gravey, J.S., N.E. Cremer and D.H. Sussdorf, 1977. Methods in Immunology 3rd Edn., Addison-Wesley publishing company Inc. New York, PP: 126-132.

Harder, A., 2002. Chemotherapeutic approaches to schistosomes: Current knowledge and outlook. Parasitol. Res., 88: 395-397.
Direct Link  |  

Hassan, M.M., A.M. Farghaly, R.A. Darwish, N. Shoukrany, I.A. El-Hayawan and A.K. Nassar, 1995. Detection of Giardia antigen in stool samples before and after treatment. J. Egypt. Soc. Parasitol., 25: 175-182.
PubMed  |  

Hassan, M.M., M.A. Badawi and M. Strand, 1992. Circulating Schistosomal antigen diagnosis and assessment of cure in individuals infected with S mansoni. Am. J. Trop. Med. Hyg., 46: 737-744.
Direct Link  |  

Hernandez, H.J., Y. Wang, N. Tzellas and M.J. Stadecker, 1997. Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. Eur. J. Immunol., 27: 1170-1176.
Direct Link  |  

Hudson, L. and F.C. Hay, 1980. Ion Exchange Chromatography. In: Practical Immunology, Hudson, L. and F.C. Hay (Eds.). 2nd Edn., Blackwell Scientific Publication, Oxford, London, USA.

Ismail, M., S. Botros, A. Metwally, S. William and A. Farghally et al., 1999. Resistance to praziquantel direct evidence from schistosoma mansoni. Am. J. Trop. Med. Hyg., 60: 932-935.
PubMed  |  

James, S.L., E.J. Pearce and A. Sher, 1985. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts J. Immunol., 134: 3432-3438.
PubMed  |  

Kiernan, J.A., 1981. Histological and Histochemical Methods: Theory and Practice. Pergamon Press, Frankfurt, Germany.

Kirkwood, R., 1989. Essentials of Medical statistics. Blackwell Scientific Publication, London, USA.

LoVerde, P.T., C. Carvalho-Queiroz, R. Cook, 2004. Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni. Mem. Inst. Oswaldo. Cruz., 99: 37-43.
CrossRef  |  

Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275.
CrossRef  |  PubMed  |  Direct Link  |  

Pacifico, L.G., C.T. Fonseca, L. Chiari, S.C. Oliveira, 2006. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine Immunobiology, 211: 97-104.
PubMed  |  

Pearce, E.J., S.L. James, S. Hieny, D.E. Lanar, and A. Sher, 1988. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a non-surface parasite antigen Proc. Natl. Acad. Sci., 85: 5678-5682.

Pearson, M.S., D.A. Pickering, H.J. McSorley, J.M. Bethony and L. Tribolet et al., 2012. Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PloS Negl. Trop. Dis., Vol. 6. 10.1371/journal.pntd.0001564

Sher, A., S.L. James, R. Correa-Oliveira, S. Hieny and E. Pearce, 1989. Schistosome vaccines: Current progress and future prospects. Parasitology, 98: S61-S68.
PubMed  |  

Smithers, S.R. and K. Gammage, 1980. The recovery of Schistosomula mansoni from the skin, lungs and hepatic portal system of native mice and mice previously exposed to S. mansoni. Evidence for two phases of parasite attrition in immune mice. Parasitology 80: 289-300.
PubMed  |  

Smithers, S.R., F. Hackett, P.O. Ali and A.J. Simpson, 1989. Protective immunization of mice against Schistosoma mansoni with purified adult worm surface membranes. Parasite Immunol., 11: 301-318.
PubMed  |  

Strand, M., 1995. Development of a vaccine against schistosomiasis Proceeding of the SRP International Conference on schistosomiasis March 12-16, 1995, Johns Hopkins University. Marriott Hotel, Cairo, Egypt -.

Verjovski-Almeida, S., R. DeMarco, E.A. Martins, P.E. Guimaraes and E.P. Ojopi et al., 2003. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat. Genet., 35: 148-157.
PubMed  |  

Von Lichtenberg, F. and J.E. Byram, 1980. Pulmonary cell reactions in natural and acquired host resistance to Schistosoma mansoni Am. J. Trop. Med. Hyg., 25: 1286-1300.
PubMed  |  

Von Lichtenberg, F., A. Sher and S. McIntyre, 1977. A lung model of schistosome immunity in mice Am. J. Pathol., 84: 105-124.
PubMed  |  

Von Lichtenberg, F., R. Correa-Oliveria and A. Sher, 1985. The fate of challenge schistosomula in the murine anti-schistosome vaccine model Am. J. Trop. Med Hyg., 34: 96-106.
PubMed  |  

WHO., 2002. TDR Strategic direction for research: Schistosomiasis. World Health Organization, Geneva, Switzerland.

Wakelin, D., 1984. Immunity to parasites. 1st Edn., Edward Arnold Publishers Ltd., London, USA.,.

Williams D.L., H. Asahi, T.T. Oke , J. Lopes da Rosa, M.J. Stadecker, 2005. Murine immune responses to a novel schistosome egg antigen, SmEP25 Int. J. Parasitol., 35: 875-882.
PubMed  |  

Williams, D.L., H. Asahi, D.J. Botkin and M.J. Stadecker, 2001. Schistosome Infection Stimulates Host CD4+ T Helper Cell and B-Cell Responses against a Novel Egg Antigen, Thioredoxin Peroxidase Infect. Immun., 69: 1134-1141.
CrossRef  |